Deep learning-based handheld device improves atrial fibrillation detection

FHS
July 19, 2023
4:10 pm

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Symptom-driven electrocardiogram (ECG) recording plays a significant role in the detection of post-ablation atrial fibrillation recurrence (AFR).

Cybin Announces the Development of a Scalable Psychedelic Facilitation Training Program, EMBARKCT | Psychedelic Invest

Cybin Inc. (NEO:CYBN / NYSE American:CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, today announced that

July 12, 2023

NMPA grants breakthrough designation to Zai lab’s repotrectinib

Repotrectinib is intended to treat NTRK-positive advanced solid tumours. Credit: Motortion Films/Shutterstock.com. China’s National Medical Products Administration’s Center for Drug Evaluation has granted breakthrough therapy

August 31, 2023

Advancing neurotoxicity research with INTEGRA pipettes

INTEGRA Biosciences has awarded 31 EVOLVE manual pipettes, GRIPTIPS® pipette tips worth US $1000, and lab accessories to the bioanalytical company DNTOX as part of its recent

October 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.